🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementKidney stone risk on GLP-1 — my results so far Page 10

Kidney stone risk on GLP-1 — my results so far

NicoleRaleigh Fri, Jan 31, 2025 at 1:10 PM 53 replies 2,543 viewsPage 10 of 11
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Mar 13, 2025 at 12:29 PM#46

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

13 11steve_okc, dave_SLC, FDA_TrackerJim and 10 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Mar 14, 2025 at 9:19 PM#47

Closing the loop on my own question.

Update — I was wrong in the opening post, specifically about the direction. Correcting it here rather than editing it away.

14 12MikeFit_NJ, InsuranceTom, WendyG_ATL and 11 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Mar 16, 2025 at 6:09 AM#48
PharmacoVig_BOS said:
Worth stating the units and the reference range whenever you post a number here.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

15 13KetoKyle, CanadaChris, ZaraB_AL and 12 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Mar 17, 2025 at 2:58 PM#49

Found this through search years later and it is still the best discussion of the question, so adding one thing. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

16 14Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 13 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Mar 18, 2025 at 11:46 PM#50

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Mar 19, 2025 at 1:46 AM
38 11JessicaM_2024, TomFromTexas, mike.trainer_LA and 35 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register